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Allogeneic mesenchymal stem cells (MSCs) present several
advantages, but recipient immune response needs to be further
elucidated. Proinflammatory priming of MSCs activated their
in vivo regulatory capacity, but repeated administrations led to
slight inflammatory reaction in an osteoarthritis equine model.
This may be associated with higher major histocompatibility
complex (MHC) expression, which would increase MSC immu-
nogenicity potentially inducing humoral mediated immune
memory. This study aimed at assessing allo-antibody production
against donor’s equine MHC (equine leukocyte antigen, ELA) in
animals that received intra-articular repeated administration of
allogeneic MSC-primed. For this purpose, we used stored samples
from a previous study. Donor and recipients ELA-haplotypes
were stablished by microsatellite typing and complement-
mediated microcytoxicity assays were carried out by exposing
target cells from the donor (unstimulated MSCs [MSC-naı̈ve],
MSC-primed or lymphocytes [control]) to sera collected at dif-
ferent time-points from 10 recipients: ELA-mismatched MSC-
naı̈ve recipients, ELA-mismatched MSC-primed recipients or
ELA-partially matched MSC-primed recipients. All animals re-
ceiving allogeneic MSCs produced allo-antibodies after the first
injection, regardless of the matching degree. However, antibody
peak production after second administration was only observed in
ELA-mismatched recipients, both of MSC-naı̈ve and MSC-
primed. Horses injected with MSC-primed produced fewer anti-
bodies but MSC-primed were more targeted in the micro-
cytoxicity assay. Thus, activated immunomodulatory profile of
MSC-primed could have led to slighter humoral response after
first administration, but these cells would be more easily targeted
by existing antibodies post-second injection. Allo-antibody pro-
duction against allogeneic equine MSCs could explain their time-
limited efficacy and may affect the safety and efficacy of this cell
therapy.
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Peripheral arterial disease is caused by atherosclerosis that
leads to obstruction of arteries and inflammation. Macrophages
and monocytes sub-types participate in different stages of repair
and regeneration of the ischemic limb, controlling angiogenesis,
myogenesis, fibrogenesis and proliferation of local cells. Here
we aimed to evaluate effects of exogenous IL-4 gene expression
over monocytes/macrophages and in the ischemic skeletal
muscle. Limb ischemia was induced by electrocauterization in
the left femoral artery of male Balb/c mice at 10–12 weeks old
age. Three days later, this limb was electroporated with 50 lg of
IL4-expressing plasmid vector (uP-IL4). In the blood, Ly6C+
monocytes decreased 34.6 – 3.6 % (before ischemia) to
15.2 – 7.2% and 24.8 – 0.8% 4 days after electroporation with
uP-IL4 and uP (empty vector), respectively. The tissue macro-
phages (F4/80+/CD206+/MHCII-) were 8.2 – 1.4% prior to is-
chemia that changed to 8.3 – 4.0% and 22.5 – 4.3% 2 days after
electroporation with uP and uP-IL4, respectively. Visual analysis
of the mouse pads showed improvement with uP-IL4 treatment
in comparison to the untreated group, but no significant super-
ficial blood flux was found between them. However, the ratio of
muscle force and muscle mass after 4 weeks showed a complete
recovery with uP-IL4 treatment, while the control groups re-
covered only 50%. In histology, we found that uP-IL4 treatment
reduced adipocytes and myofibers with peripheral nuclei,
showing healthier and normalized skeletal muscle. Collectively,
it seems that the overexpression of IL-4 in the ischemic limb
recruited more anti-inflammatory monocytes and macrophages
temporarily, which promoted ischemic muscle repair and re-
generation with less adipocytes.
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Cell-matrix interaction plays a major role in cell differentia-
tion alongside growth factors and cell-cell interactions. In-
vestigation an effective nanomaterials promoting adhesion,
proliferation, and differentiation of cells is crucial in tissue en-
gineering. Iron oxide magnetic nanoparticles (MNPs) is one of
the promising nanomaterials that may be used to modify cell
substrate. The manipulation of MNPs by an external magnetic
field allows constructing complex surface for cell culturing. In
this study, we investigate the influence of MNPs-based surface
on the differentiation potential of adipose-derived mesenchymal
stem cells. The study was performed according to Program of
Competitive Growth of KFU and funded by the subsidy allo-
cated to KFU (project 16.2822.2017/4.6), the Russian Pre-
sidential grant MK-4498.2018.4 and RFBR project 18-53-
80067. MNPs were synthesized by the method of chemical re-
duction and characterized by both atomic force (AFM) and hy-
perspectral dark-field microscopy (HSM). Next, the surface of
MNPs at concentrations 0.3–1.2 mg/ml was constructed by the
method of colloid immobilization. The roughness of samples
was analyzed by AFM. Biocompatibility of samples was mea-
sured by MTT-assay. Differentiation of cells into chondrocytes,
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